Clincosm LogoSign in Get a demo

Influenza

Showing NaN - NaN of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

Influenza Trial in United States (Quadrivalent influenza vaccine, high-dose, Quadrivalent influenza vaccine, standard dose)

Suspended
  • Influenza
  • Quadrivalent influenza vaccine, high-dose
  • Quadrivalent influenza vaccine, standard dose
  • San Diego, California
  • +9 more
May 3, 2022

Influenza Trial in United States (QIV-HD, Licensed TIV-HD1, Investigational TIV-HD2)

Completed
Has Results
  • Influenza
  • QIV-HD
  • +2 more
  • Anaheim, California
  • +35 more
Mar 24, 2022

Influenza Trial in United States (FluBlok®, Placebo)

Completed
Has Results
  • Influenza
  • FluBlok®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),

Completed
Has Results
  • Influenza
  • High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
  • +4 more
  • San Diego, California
  • +15 more
Mar 24, 2022

Influenza Trial in Bardstown, Metairie, Salt Lake City (Fluzone Quadrivalent vaccine, 2018-2019 formulation, Flublok

Completed
Has Results
  • Influenza
  • Fluzone Quadrivalent vaccine, 2018-2019 formulation
  • +2 more
  • Bardstown, Kentucky
  • +2 more
Mar 15, 2022

Influenza Trial in Bardstown, Salt Lake City (Fluzone Quadrivalent vaccine, no preservative (0.5-mL), 2019-2020 formulation,

Completed
Has Results
  • Influenza
  • Fluzone Quadrivalent vaccine, no preservative (0.5-mL), 2019-2020 formulation
  • Fluzone High-Dose vaccine, 2019-2020 formulation
  • Bardstown, Kentucky
  • +1 more
Mar 15, 2022

Influenza, Human, Virus Diseases Trial in United States (QIVc, Comparator QIV)

Completed
Has Results
  • Influenza
  • +2 more
  • QIVc
  • Comparator QIV
  • Mobile, Alabama
  • +46 more
Dec 13, 2021

Influenza Trial in Worldwide (Liquid CAIV-T)

Completed
  • Influenza
  • Liquid CAIV-T
  • Hoover, Alabama
  • +160 more
Sep 10, 2021

Influenza Trial in United States (Peramivir)

Completed
Has Results
  • Influenza
  • Brooksville, Florida
  • +14 more
Feb 26, 2021

Influenza Trial in United States (Peramivir, Placebo)

Terminated
Has Results
  • Influenza
  • Millbrook, Alabama
  • +95 more
Feb 24, 2021

Influenza Trial in Worldwide (Baloxavir Marboxil, Oseltamivir)

Completed
Has Results
  • Influenza
  • Birmingham, Alabama
  • +36 more
Apr 28, 2020

Influenza Trial in Finland, Poland, United States (Cell culture-derived influenza vaccine, Egg-derived influenza virus vaccine,

Completed
Has Results
  • Influenza
  • Cell culture-derived influenza vaccine
  • +2 more
  • Denver, Colorado
  • +55 more
Aug 2, 2019

Influenza, Healthy Trial in United States (FluMist trivalent (2015-2016), FluMist Quadrivalent (2015-2016), FluMist Quadrivalent

Completed
Has Results
  • Influenza
  • Healthy
  • FluMist trivalent (2015-2016)
  • +2 more
  • Savannah, Georgia
  • +11 more
Nov 16, 2018

Influenza Trial in Mexico, United States (FluLaval™ Quadrivalent, Fluzone® Quadrivalent)

Completed
Has Results
  • Influenza
  • FluLaval™ Quadrivalent
  • Fluzone® Quadrivalent
  • Birmingham, Alabama
  • +65 more
Aug 9, 2018

Influenza Trial in Worldwide (Trivalent influenza vaccine (TIVc), Trivalent influenza vaccine-licensed)

Completed
Has Results
  • Influenza
  • Trivalent influenza vaccine (TIVc)
  • Trivalent influenza vaccine-licensed
  • Phoenix, Arizona
  • +26 more
Jun 11, 2018

Influenza Trial in Worldwide (GSK Bio's influenza vaccine GSK2186877A, Fluarix TM)

Completed
Has Results
  • Influenza
  • GSK Bio's influenza vaccine GSK2186877A
  • Fluarix TM
  • Alabaster, Alabama
  • +273 more
May 8, 2018

Influenza Trial in United States (Fluarix™, Fluzone)

Completed
Has Results
  • Influenza
  • Fluarix™
  • Fluzone
  • Antioch, California
  • +39 more
May 8, 2018

Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)

Completed
Has Results
  • Influenza
  • 40 mg Laninamivir Octanoate
  • +2 more
  • Scottsboro, Alabama
  • +220 more
May 29, 2018

Influenza Trial in Worldwide (Nitazoxanide, Oseltamivir, Placebo Oral Tablet)

Completed
  • Influenza
  • Birmingham, Alabama
  • +166 more
Mar 27, 2018

Influenza Trial in United States (High-dose quadrivalent influenza virus vaccine, High-dose influenza virus vaccine, High-dose

Completed
  • Influenza
  • High-dose quadrivalent influenza virus vaccine
  • +2 more
  • Milford, Connecticut
  • +8 more
Feb 5, 2018

Influenza Trial in United States (CSL425, Placebo)

Completed
Has Results
  • Influenza
  • CSL425
  • Placebo
  • Huntsville, Alabama
  • +10 more
Oct 18, 2017

Influenza Trial in United States (Flublok Quadrivalent Influenza Vaccine, Inactivated Influenza Vaccine)

Completed
Has Results
  • Influenza
  • Flublok Quadrivalent Influenza Vaccine
  • Inactivated Influenza Vaccine
  • Mobile, Alabama
  • +37 more
Sep 26, 2017